Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03336216
Title A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | GBR | ESP | DNK | DEU | CHE | CAN

Facility Status City State Zip Country Details
Mayo Clinic in Rochester, Minnesota Phoenix Arizona 85054 United States Details
HonorHealth Research Institute Scottsdale Arizona 85258 United States Details
Local Institution - 0007 Los Angeles California 90095 United States Details
University Of Colorado Aurora Colorado 80045 United States Details
Florida Cancer Specialists - South Fort Myers Florida 33901 United States Details
Florida Cancer Specialists - North Saint Petersburg Florida 33705 United States Details
Local Institution - 0001 Baltimore Maryland 21287 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02114 United States Details
Dana Farber Cancer Institute. Boston Massachusetts 02114 United States Details
Local Institution - 0010 Boston Massachusetts 02114 United States Details
Washington University Saint Louis Missouri 63110 United States Details
Local Institution - 0012 New York New York 10016 United States Details
Local Institution - 0005 New York New York 10065 United States Details
Local Institution - 0006 Philadelphia Pennsylvania 19104 United States Details
Local Institution - 0009 Pittsburgh Pennsylvania 15232 United States Details
Tennessee Oncology Chattanooga Nashville Tennessee 37203 United States Details
Local Institution - 0013 Dallas Texas 75390 United States Details
Local Institution - 0011 Houston Texas 77030 United States Details
University Of Washington Seattle Washington 98109 United States Details
Cross Cancer Institute Edmonton Alberta T6G 1Z2 Canada Details
Local Institution - 0037 Kingston Ontario K7L 2V7 Canada Details
Local Institution - 0035 Toronto Ontario M5G 2M9 Canada Details
Local Institution - 0041 Herlev 2730 Denmark Details
Local Institution - 0032 Heidelberg 69120 Germany Details
Local Institution - 0029 Mannheim 68167 Germany Details
Universitaetsklinikum Ulm Ulm 89081 Germany Details
Local Institution - 0030 Wuerzburg 97080 Germany Details
Local Institution - 0025 Padova Padova Italy Details
Local Institution - 0026 Roma 00168 Italy Details
Local Institution - 0023 Kashiwa-shi Chiba 2778577 Japan Details
Local Institution - 0022 Chuo-ku Tokyo 1040045 Japan Details
Local Institution - 0018 Seoul 03080 Korea, Republic of Details
Local Institution - 0017 Seoul 06351 Korea, Republic of Details
Local Institution - 0021 Barcelona 08035 Spain Details
Local Institution - 0019 Madrid 28007 Spain Details
Local Institution - 0020 Madrid 28041 Spain Details
Local Institution - 0033 Chur 7000 Switzerland Details
Local Institution - 0034 Lausanne 1011 Switzerland Details
Local Institution - 0024 Taipei City 100 Taiwan Details
Local Institution - 0031 Taipei 112 Taiwan Details
Local Institution - 0016 Glasgow Lanarkshire G12 0YN United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field